We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Actavis, GSK Escape Some Third-Party RICO Claims; MDL Judge Keeps Rest

(August 31, 2016, 11:09 AM EDT) -- CHICAGO — The federal judge overseeing the testosterone multidistrict litigation on Aug. 2 dismissed negligent misrepresentation and substantive Racketeer Influenced and Corrupt Organizations (RICO) Act claims made by insurer Medical Mutual of Ohio against defendants Actavis PLC and GlaxoSmithKline PLC (GSK) but said other claims in the insurer’s second amended complaint against the two companies and against other defendants survive (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, N.D. Ill., Eastern Div.).

(Opinion and order available. Document #28-160901-019B.)

In 2014,...
To view the full article, register now.